drugset / Trial / NCT02328768
Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children
Expanded access
Approved for marketing
University of Nebraska
Children's Hospital and Medical Center, Omaha, Nebraska · collab
Summary
The overall purpose of this study is to determine if replacing standard soybean oil based fat emulsions with Omegaven®, a fish oil based fat emulsion, can reverse or prevent the progression of parenteral nutrition associated liver disease. It is a compassionate use protocol for patients who already have significant liver disease related to parenteral nutrition.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omegaven | Other / unclassified | — | Intravenous |